| Authors: |
Lee JSF; Drugs for Neglected Diseases Initiative, Geneva, Switzerland. Electronic address: jlee@dndi.org., Cohen RM; Drugs for Neglected Diseases initiative, New York, NY, USA., Khan RA; Hospital Kuala Lumpur, Ministry of Health Malaysia, Kuala Lumpur, Malaysia., Burry J; Médecins Sans Frontières Access Campaign, Geneva, Switzerland., Casas EC; Medecins Sans Frontières, Cape Town, South Africa., Chung HY; Drugs for Neglected Diseases Initiative, Kuala Lumpur, Malaysia., Costa LH; Ministério da Saúde, Federal District, Brazil., Ford N; World Health Organization, Geneva, Switzerland., Galvao DLN; Drugs for Neglected Diseases Initiative, Rio de Janeiro, Brazil., Giron N; Pan American Health Organization Strategic Fund, Washington, DC, USA., Jarvis JN; Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, UK; UK & Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana., Mondal M; Drugs for Neglected Diseases Initiative, New Delhi, India., Odionyi JJ; Drugs for Neglected Diseases Initiative, Nairobi, Kenya., Casas CP; Unitaid, Global Health Campus, Geneva, Switzerland., Rangaraj A; Department of HIV, Hepatitis and STIs, World Health Organization, Geneva, Switzerland., Rode J; Drugs for Neglected Diseases Initiative, Rio de Janeiro, Brazil., Ruffell C; Drugs for Neglected Diseases Initiative Global Antibiotic R&D Partnership, Cape Town, South Africa., Sued O; Pan American Health Organization, Washington, DC, USA., Ribeiro I; Drugs for Neglected Diseases Initiative, Geneva, Switzerland. |